These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 34638165)

  • 1. Impact of centrifugation time and pneumatic tube transport on plasma concentrations of direct oral anticoagulants.
    Roginski E; Nissen PH; Hojbjerg JA; Grove EL; Hvas AM
    Int J Lab Hematol; 2022 Feb; 44(1):216-222. PubMed ID: 34638165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of DOAC Filter, a new device to remove direct oral anticoagulants from plasma samples.
    Sevenet PO; Cucini V; Hervé T; Depasse F; Carlo A; Contant G; Mathieu O
    Int J Lab Hematol; 2020 Oct; 42(5):636-642. PubMed ID: 32567799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of centrifugation on thrombin generation in healthy subjects and in patients treated with direct oral anticoagulants.
    Hardy M; Dellanoce C; Douxfils J; Carlo A; Lessire S; Bouvy C; Testa S; Mullier F
    Int J Lab Hematol; 2021 Dec; 43(6):1585-1592. PubMed ID: 34252264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of direct oral anticoagulants on thrombin generation on Ceveron TGA.
    Pfrepper C; Behrendt LC; Bönigk H; Siegemund T; Metze M; Franke D; Petros S; Siegemund A
    Int J Lab Hematol; 2022 Feb; 44(1):193-201. PubMed ID: 34585540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of DOAC-Stop on lupus anticoagulant testing in plasma samples of venous thromboembolism patients receiving direct oral anticoagulants.
    Ząbczyk M; Kopytek M; Natorska J; Undas A
    Clin Chem Lab Med; 2019 Aug; 57(9):1374-1381. PubMed ID: 30763261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of DOAC Dipstick Test for Detecting Direct Oral Anticoagulants in Urine Compared with a Clinically Relevant Plasma Threshold Concentration.
    Örd L; Marandi T; Märk M; Raidjuk L; Kostjuk J; Banys V; Krause K; Pikta M
    Clin Appl Thromb Hemost; 2022; 28():10760296221084307. PubMed ID: 35249379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poor comparability of coagulation screening test with specific measurement in patients receiving direct oral anticoagulants: results from a multicenter/multiplatform study.
    Testa S; Legnani C; Tripodi A; Paoletti O; Pengo V; Abbate R; Bassi L; Carraro P; Cini M; Paniccia R; Poli D; Palareti G
    J Thromb Haemost; 2016 Nov; 14(11):2194-2201. PubMed ID: 27566988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interlaboratory variability in the measurement of direct oral anticoagulants: results from the external quality assessment scheme.
    Tripodi A; Chantarangkul V; Legnani C; Testa S; Tosetto A
    J Thromb Haemost; 2018 Mar; 16(3):565-570. PubMed ID: 29322630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct oral anticoagulants and heparins: laboratory values and pitfalls in 'bridging therapy'.
    Eller T; Flieder T; Fox V; Gripp T; Dittrich M; Kuhn J; Alban S; Knabbe C; Birschmann I
    Eur J Cardiothorac Surg; 2017 Apr; 51(4):624-632. PubMed ID: 28043992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct oral anticoagulant adsorption: Impact on lupus anticoagulant testing-Review of the literature and evaluation on spiked and patient samples.
    De Kesel PM; Devreese KMJ
    J Thromb Haemost; 2020 Aug; 18(8):2003-2017. PubMed ID: 32400112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of four direct oral anticoagulants on rotational thromboelastometry (ROTEM).
    Seyve L; Richarme C; Polack B; Marlu R
    Int J Lab Hematol; 2018 Feb; 40(1):84-93. PubMed ID: 28980758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interference of DOACs in different DRVVT assays for diagnosis of lupus anticoagulants.
    Flieder T; Weiser M; Eller T; Dittrich M; von Bargen K; Alban S; Kuhn J; Knabbe C; Birschmann I
    Thromb Res; 2018 May; 165():101-106. PubMed ID: 29627719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma levels do not predict thrombin generation in patients taking direct oral anticoagulants.
    Metze M; Klöter T; Stöbe S; Rechenberger B; Siegemund R; Siegemund T; Laufs U; Petros S; Pfrepper C
    Int J Lab Hematol; 2021 Dec; 43(6):1539-1548. PubMed ID: 34097808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Limitations of Specific Coagulation Tests for Direct Oral Anticoagulants: A Critical Analysis.
    Ebner M; Birschmann I; Peter A; Härtig F; Spencer C; Kuhn J; Rupp A; Blumenstock G; Zuern CS; Ziemann U; Poli S
    J Am Heart Assoc; 2018 Oct; 7(19):e009807. PubMed ID: 30371316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An optimized dRVVT-based assay to estimate the intensity of anticoagulation in patients treated with direct oral anticoagulants.
    Sennesael AL; Exner T; Chatelain B; Lessire S; Larock AS; Vancraeynest C; Pochet L; Dogné JM; Spinewine A; Mullier F; Douxfils J
    Thromb Res; 2017 Sep; 157():29-37. PubMed ID: 28686914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitivity of routine coagulation assays to direct oral anticoagulants: patient samples versus commercial drug-specific calibrators.
    Lim MS; Chapman K; Swanepoel P; Enjeti AK
    Pathology; 2016 Dec; 48(7):712-719. PubMed ID: 27780603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stability of direct oral anticoagulants in whole blood and plasma from patients in steady state treatment.
    McGrail R; Revsholm J; Nissen PH; Grove EL; Hvas AM
    Thromb Res; 2016 Dec; 148():107-110. PubMed ID: 27835819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of dabigatran and rivaroxaban by ultra-performance liquid chromatography-tandem mass spectrometry and coagulation assays after major orthopaedic surgery.
    Schellings MW; Boonen K; Schmitz EM; Jonkers F; van den Heuvel DJ; Besselaar A; Hendriks JG; van de Kerkhof D
    Thromb Res; 2016 Mar; 139():128-34. PubMed ID: 26916310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of dabigatran, rivaroxaban and apixaban target-specific assays in a multicenter French study.
    Gouin-Thibault I; Freyburger G; de Maistre E; Susen S; Delavenne X; Golmard JL; Gruel Y; Sié P;
    Thromb Res; 2017 Oct; 158():126-133. PubMed ID: 28892657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening test for direct oral anticoagulants with the dilute Russell viper venom time.
    Pratt J; Crispin P
    Eur J Haematol; 2018 Jun; 100(6):567-574. PubMed ID: 29486103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.